Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Yidu Tech's share price for the quarter that ended in Sep. 2023 was HK$3.98. Yidu Tech's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 1,052.9 Mil. Therefore, Yidu Tech's market cap for the quarter that ended in Sep. 2023 was HK$4,190.4 Mil.
Yidu Tech's quarterly market cap
increased
from Sep. 2022 (HK$4,782.8 Mil) to Mar. 2023 (HK$7,580.3 Mil) but then
declined
from Mar. 2023 (HK$7,580.3 Mil) to Sep. 2023 (HK$4,190.4 Mil).
Yidu Tech's annual market cap
declined
from Mar. 2021 (HK$32,845.6 Mil) to Mar. 2022 (HK$9,664.1 Mil) and
declined
from Mar. 2022 (HK$9,664.1 Mil) to Mar. 2023 (HK$7,580.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Yidu Tech's Enterprise Value for Today is HK$-47.6 Mil.
Yidu Tech Market Cap Historical Data
The historical data trend for Yidu Tech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Yidu Tech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yidu Tech's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's Market Cap distribution charts can be found below:
* The bar in red indicates where Yidu Tech's Market Cap falls into.
Yidu Tech Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Yidu Tech's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yidu Tech (HKSE:02158) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Yidu Tech Market Cap Related Terms
Thank you for viewing the detailed overview of Yidu Tech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 33% of revenue, life science solutions 30%, and health management solutions 27%, in fiscal 2022.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02158 has been successfully added to your 